Aerie Pharmaceuticals Stock Forecast NASDAQ:AERI

Price Target and Analyst Ratings

Most Recent Rating

On September 16, 2021 "HC Wainwright" gave "$29.00" rating for AERI. The price target was changed from $11.96 to 23.8%.

Last 30 Days

Historical Ratings

Date	Rating	Action	Authority	Current Price	Target Price
2021-09-16	$29.00	Reiterated by	HC Wainwright	$12.34	$11.96→23.8%
2021-09-10	$24.00	Initiated by	Needham & Company LLC	$16.63	$16.63+0.0%
2021-08-27	$24.00	Initiated by	Needham & Company LLC	$14.68	$14.68+0.0%
2021-08-05	$26.00 - $24.00	Target Lowered by	Needham & Company LLC	$15.01	$15.00→1.6%
2021-07-23	$26.00	Initiated by	Needham & Company LLC	$15.51	$15.510.0%
2021-07-22	$28.00	Reiterated by	Mizuho	$15.53	$16.19+2.9%
2021-07-16	$26.00	Initiated by	Needham & Company LLC	$15.27	$15.270.0%
2021-07-13	$15.65	Target Set by	Raymond James	$15.62	$15.65→0.9%
2021-07-12		Reiterated by	Raymond James	$15.65	$15.65→0.9%
2021-07-09	$26.00	Initiated by	Needham & Company LLC	$15.79	$15.79+3.1%
2021-07-02	Buy	Initiated by	Needham & Company LLC	$16.01	$26.00
2021-04-30	Buy	Initiated by	Needham & Company LLC	$17.13	$26.00
2021-04-23	Buy	Initiated by	Needham & Company LLC	$17.65	$26.00
2021-03-01	Buy	Reiterated by	HC Wainwright	$19.18
2021-02-05	Buy	Initiated by	Needham & Company LLC	$17.68	$26.00
2020-12-28	Buy	Reiterated by	Mizuho	$14.06	$28.00
2020-12-28	Buy	Reiterated by	Needham & Company LLC	$14.06	$26.00
2020-11-09	Buy	Target Lowered by	HC Wainwright	$12.38	$31.00 → $29.00
2020-11-06	Buy	Reiterated by	Mizuho	$10.56
2020-10-19	Neutral - Underperform	Downgraded by	BofA Securities	$9.92	$14.00 → $9.00
2020-10-19	Neutral - Underperform	Downgraded by	Bank of America	$9.92	$14.00 → $9.00
2020-10-19	Neutral - Underperform	Downgraded by	Bank of America	$9.92	$9.00
2020-10-19	Neutral - Underperform	Downgraded by	Bank of America	$9.92
2020-10-05	Hold	Reiterated by	Raymond James	$12.25
2020-10-05	Buy	Reiterated by	Needham & Company LLC	$12.25	$26.00
2020-09-28	Hold	Reiterated by	Raymond James	$11.03
2020-09-08	Buy	Initiated by	Guggenheim	$11.95	$20.00
2020-09-08	Hold	Reiterated by	Raymond James	$11.95
2020-08-24	Hold	Reiterated by	Raymond James	$11.04
2020-08-10	Buy	Target Lowered by	Citigroup	$12.89	$38.00 → $32.00
2020-08-07	Buy	Target Raised by	Mizuho	$12.61	$27.00 → $29.00
2020-08-07	Buy	Target Lowered by	Needham & Company LLC	$12.61	$32.00 → $26.00
2020-08-07		Target Lowered by	Piper Sandler	$12.61	$35.00 → $25.00
2020-07-28	Buy	Reiterated by	Mizuho	$12.33	$29.00
2020-07-24	Buy	Initiated by	Needham & Company LLC	$12.18	$32.00
2020-07-06	Buy	Initiated by	Needham & Company LLC	$13.95	$38.00
2020-06-26	Buy	Initiated by	Needham & Company LLC	$14.88	$38.00
2020-06-19	Buy	Initiated by	Needham & Company LLC	$15.60	$38.00
2020-05-07	Buy	Target Lowered by	SunTrust Banks	$14.45	$26.00 → $22.00
2020-05-07	Buy	Target Lowered by	Mizuho	$14.45	$34.00 → $29.00
2020-05-07	Buy	Target Lowered by	HC Wainwright	$14.45	$37.00 → $31.00
2020-05-07	Overweight	Target Lowered by	Piper Sandler	$14.45	$45.00 → $35.00
2020-05-07	Buy	Reiterated by	Needham & Company LLC	$14.45
2020-04-30	Buy	Target Lowered by	Needham & Company LLC	$15.24	$40.00 → $38.00
2020-04-24	Buy	Reiterated by	Needham & Company LLC	$14.30	$40.00
2020-04-13	Buy	Target Lowered by	Mizuho	$15.11	$54.00 → $34.00
2020-04-13	Outperform	Target Lowered by	Oppenheimer	$15.11	$28.00 → $26.00
2020-04-13	Buy	Reiterated by	Needham & Company LLC	$15.11	$40.00

AERI Stock Trend

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($13.01) are considered to be a "second chance" to get out. According to the fan-theory $9.50 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-09-20	$12.97	$14.73	$16.48
2021-09-21	$12.93	$14.69	$16.44
2021-09-22	$12.89	$14.65	$16.40
2021-09-23	$12.85	$14.61	$16.36
2021-09-24	$12.81	$14.57	$16.32
2021-09-27	$12.77	$14.53	$16.28
2021-09-28	$12.73	$14.49	$16.24
2021-09-29	$12.69	$14.45	$16.20
2021-09-30	$12.65	$14.41	$16.16
2021-10-01	$12.61	$14.37	$16.12
2021-10-04	$12.57	$14.33	$16.08
2021-10-05	$12.53	$14.29	$16.04
2021-10-06	$12.49	$14.25	$16.00
2021-10-07	$12.45	$14.21	$15.96
2021-10-08	$12.41	$14.17	$15.92
2021-10-11	$12.37	$14.13	$15.88
2021-10-12	$12.33	$14.09	$15.84
2021-10-13	$12.29	$14.05	$15.80
2021-10-14	$12.25	$14.01	$15.76
2021-10-15	$12.21	$13.97	$15.72
2021-10-18	$12.17	$13.93	$15.68
2021-10-19	$12.13	$13.89	$15.64
2021-10-20	$12.09	$13.85	$15.60
2021-10-21	$12.05	$13.81	$15.56
2021-10-22	$12.01	$13.77	$15.52
2021-10-25	$11.97	$13.73	$15.48
2021-10-26	$11.93	$13.69	$15.44
2021-10-27	$11.89	$13.65	$15.40
2021-10-28	$11.85	$13.61	$15.36
2021-10-29	$11.81	$13.57	$15.32

About Aerie Pharmaceuticals

Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases. Its product candidates include Rhopressa, a once-daily eye drop, which has completed Phase III registration trials for the reduction of intraocular pressure (IOP) in patients with glaucoma or ocular hypertension; and Roclatan, a once-dai... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!